(Q34024227)

30 July 2017

Randomized clinical trials with biomarkers: design issues (English)

1 reference

30 July 2017

0 references

1

Boris Freidlin

1 reference

30 July 2017

Lisa M McShane

2

1 reference

PubMed ID

20075367

30 July 2017

Edward L Korn

series ordinal

3

1 reference

PubMed ID

20075367

30 July 2017

language of work or name

English

0 references

publication date

14 January 2010

1 reference

Journal of the National Cancer Institute

30 July 2017

1 reference

30 July 2017

102

1 reference

30 July 2017

152-160

1 reference

30 July 2017

3

1 reference

Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges.

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911042

Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911042

Monitoring for lack of benefit: a critical component of a randomized clinical trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911042

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911042

The use of genomics in clinical trial design

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911042

Setting the benchmark for tailoring treatment with EGFR tyrosine kinase inhibitors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911042

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911042

Clinical trials design and treatment tailoring: general principles applied to breast cancer research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911042

Clinical trial designs for predictive marker validation in cancer treatment trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911042

Clinical trial design for microarray predictive marker discovery and assessment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911042

The roles of FLT3 in hematopoiesis and leukemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911042

A Multiple Testing Procedure for Clinical Trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911042

Clinical trial designs for prospective validation of biomarkers

5 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP477

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP477

Bias as a threat to the validity of cancer molecular-marker research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP477

Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911042

Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer

29 October 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP477

p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610

21 January 2018

1 reference

12 December 2020

TAILORx: trial assigning individualized options for treatment (Rx)

1 reference

12 December 2020

A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer

1 reference

12 December 2020

The process to discover and develop biomarkers for cancer: a work in progress

1 reference

12 December 2020

Evaluating the efficiency of targeted designs for randomized clinical trials

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJP477

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

PubMed ID

20075367